Vivimed Labs Ltd Share Price Vivimed Labs.

12.50

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

12.27

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 05-Nov-2019 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2019 ,inter alia, to consider and approve Notice of Board Meeting for considering un-audited financial results and preferential issue of Securities & Closure of Trading Window Outcome of the Meeting of the Board of Directors of the Company (As Per BSE Announcement dated on 14/11/2019)
Board Meeting - 31-Jul-2019 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2019 ,inter alia, to consider and approve Notice for Board Meeting of Vivimed Labs Limited scheduled on August 09, 2019 and Closure of Trading Window Outcome of the Meeting of the Board of Directors of the Company (As Per BSE Announcement Dated 09.08.2019)
Board Meeting - 17-May-2019 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2019 ,inter alia, to consider and approve In compliance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board Meeting of Vivimed Labs Limited will be held on Thursday, May 30, 2019 at Hyderabad inter- alia to discuss and approve Audited Annual Financial Statements for the year ended March 31, 2019 In furtherance to our intimation letter dated April 03, 2019 and pursuant to the Code of Conduct for Prohibition of Insider Trading of the Company, the Trading Window for dealing in the Securities of Vivimed Labs Limited was closed for insiders from April 03, 2019 and will continue to remain closed till Saturday, June 01, 2019 (both days inclusive) for Insiders of Vivimed Labs Limited Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that: 1. The Board of Directors (the Board) at its meeting held today i.e. May 30, 2019 has considered and approved the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31, 2019. Please find enclosed said Audited Results along with Audit Report and Form A. 2. The meeting of the Board of Directors of the Company commenced at 3:00 P.M and concluded at 11.00 P.M . (As Per BSE Announcement Dated On 31/05/2019)
Board Meeting - 16-Apr-2019 - -
Allotment of Shares pursuant to exercise of Employee Stock Options under the Vivimed Labs ESOS 2010 We wish to inform you that the Nomination And Remuneration Committee of the Board of Directors of the Company through a resolution passed at its meeting held on 16th April, 2019, has allotted 3,90,000 equity shares of Rs.2/- each fully paid up to the allottees upon exercise of stock options pursuant to Vivimed Labs ESOS 2010 With the allotment of the above shares, the equity base of the Company stands increased from present level of 8,25,23,915 (Nos.) to 8,29,13,915 (Nos.) equity shares of Rs.2/- each. CANCELLATION OF STOCK OPTIONS: The Nomination and Remuneration Committee at its Meeting held on 16th April, 2019 took note of cancellation of 6,05,000 Stock Options granted under Vivimed Labs ESOS 2010.
Board Meeting - 04-Feb-2019 - -
VIVIMED LABS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2019 ,inter alia, to consider and approve With reference to the captioned subject, this is to inform you that a meeting of the Board of Directors of the Company will be held on Thursday, February 14, 2019, inter alia, to consider and approve the unaudited Financial Results of the Company for the quarter ended 31/12/2018. In view of this, pursuant to SEBI (Prohibition of Insider Trading) Regulations and Companys Internal Code for Prevention of Insider Trading, the trading window for dealing in securities of the Company shall remain closed from February 04, 2019 to February 14, 2019 (both days inclusive) and shall reopen after the expiry of 48 hours after the public announcement of unaudited financial results is made. The Board of Directors of the Company at its meeting held on Thursday, February 14, 2019 inter alia, have approved / resolved/ taken note of the following: 1. Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, considered and approved the submission of the Un audited Financial Results (Standalone & Consolidated) for the Quarter and 9 months ended December 31, 2018 attached herewith; 2. Auditorss Limited Review Report on the Un-audited Financial Statements of the Company for the Quarter and 9 months ended December 31, 2018. An earnings related presentation including business highlights will be uploaded on the companys website www.vivimedlabs.com (As Per BSE Announcement Dated 14.02.2019)